2019
DOI: 10.1016/s0618-8278(19)30354-8
|View full text |Cite
|
Sign up to set email alerts
|

THU-073-The use of APRI and FIB-4 scores versus transient elastography for the assessment of liver fibrosis stage in patients with chronic hepatitis C: Is it possible to reduce the need for elastography?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…[ 16 ] Recently, researches are conducted to define a threshold cut-off for both biochemical scores to diagnose severe liver fibrosis to defer TE. [ 7 17 ] FIB outperforms APRI, with a score of less than 1.08-1.2 as a threshold to exclude severe liver fibrosis found in different population. [ 11 13 ] Because of all the challenges associated with the assessment of liver fibrosis, WHO and EASL recommend using APRI and FIB-4 to guide monitoring and treatment decisions in HCV patients for a cost-effective care plan.…”
Section: Introductionmentioning
confidence: 99%
“…[ 16 ] Recently, researches are conducted to define a threshold cut-off for both biochemical scores to diagnose severe liver fibrosis to defer TE. [ 7 17 ] FIB outperforms APRI, with a score of less than 1.08-1.2 as a threshold to exclude severe liver fibrosis found in different population. [ 11 13 ] Because of all the challenges associated with the assessment of liver fibrosis, WHO and EASL recommend using APRI and FIB-4 to guide monitoring and treatment decisions in HCV patients for a cost-effective care plan.…”
Section: Introductionmentioning
confidence: 99%